(0.44%) 5 040.35 points
(0.28%) 38 010 points
(0.86%) 15 740 points
(0.33%) $79.26
(2.17%) $1.974
(-0.35%) $2 303.00
(-0.80%) $26.54
(0.43%) $959.00
(0.27%) $0.936
(0.46%) $11.08
(0.21%) $0.800
(-1.34%) $92.01
-0.59% $ 32.09
Live Chart Being Loaded With Signals
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand...
Stats | |
---|---|
Dzisiejszy wolumen | 38 599.00 |
Średni wolumen | 42 879.00 |
Kapitalizacja rynkowa | 6.20B |
EPS | $0.269 ( 2020-09-29 ) |
Następna data zysków | ( $0 ) 2024-07-09 |
Last Dividend | $0.570 ( 2023-09-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 24.13 |
ATR14 | $0.0290 (0.09%) |
Wolumen Korelacja
EBOS Group Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
EBOS Group Ltd Korelacja - Waluta/Towar
EBOS Group Ltd Finanse
Annual | 2023 |
Przychody: | $13.32B |
Zysk brutto: | $1.70B (12.76 %) |
EPS: | $1.450 |
FY | 2023 |
Przychody: | $13.32B |
Zysk brutto: | $1.70B (12.76 %) |
EPS: | $1.450 |
FY | 2022 |
Przychody: | $11.90B |
Zysk brutto: | $1.38B (11.60 %) |
EPS: | $1.270 |
FY | 2021 |
Przychody: | $9.89B |
Zysk brutto: | $1.07B (10.78 %) |
EPS: | $1.232 |
Financial Reports:
No articles found.
EBOS Group Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.380 (N/A) |
$0 (N/A) |
$0.426 (N/A) |
$0 (N/A) |
$0.570 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.178 | 2014-03-07 |
Last Dividend | $0.570 | 2023-09-07 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $6.19 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.85 | -- |
Div. Sustainability Score | 8.16 | |
Div.Growth Potential Score | 2.85 | |
Div. Directional Score | 5.50 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NST.AX | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
FMG.AX | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
PRU.AX | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
ASX.AX | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
IGO.AX | Ex Dividend Knight | 2023-09-13 | Annually | 0 | 0.00% | |
SFC.AX | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
CDA.AX | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
MFF.AX | Ex Dividend Knight | 2023-10-06 | Semi-Annually | 0 | 0.00% | |
TOP.AX | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
CYC.AX | Ex Dividend Junior | 2023-09-01 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0203 | 1.500 | 9.59 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0367 | 1.200 | 8.78 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0972 | 1.500 | -0.0316 | -0.0474 | [0.1 - 1] |
payoutRatioTTM | 0.823 | -1.000 | 1.770 | -1.770 | [0 - 1] |
currentRatioTTM | 1.131 | 0.800 | 9.34 | 7.48 | [1 - 3] |
quickRatioTTM | 0.643 | 0.800 | -0.923 | -0.738 | [0.8 - 2.5] |
cashRatioTTM | 0.0797 | 1.500 | -0.668 | -1.002 | [0.2 - 2] |
debtRatioTTM | 0.199 | -1.500 | 6.68 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 5.16 | 1.000 | 9.20 | 9.20 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.734 | 2.00 | 9.42 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.063 | 2.00 | 9.47 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.527 | -1.500 | 7.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0737 | 1.000 | -2.11 | -2.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0367 | 1.000 | -1.266 | -1.266 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.238 | 1.000 | 9.79 | 9.79 | [0.2 - 2] |
assetTurnoverTTM | 1.809 | 0.800 | 1.270 | 1.016 | [0.5 - 2] |
Total Score | 8.16 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 23.77 | 1.000 | 7.70 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0972 | 2.50 | -0.0203 | -0.0474 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.063 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.94 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.734 | 2.00 | 9.42 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.823 | 1.500 | 1.770 | -1.770 | [0 - 1] |
pegRatioTTM | -1.070 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0262 | 1.000 | -1.844 | 0 | [0.1 - 0.5] |
Total Score | 2.85 |
EBOS Group Ltd
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej